{"retracted":false,"update":{"timestamp":1415059200000,"doi":"10.1007/s10549-014-3176-3","type":"correction"},"doi":"10.1007/s10549-012-2260-9","journal":"Breast Cancer Research and Treatment","publisher":"Springer Nature","title":"Erratum to: Evaluation of IGF1R and phosphorylated IGF1R as targets in HER2-positive breast cancer cell lines and tumours"}
